Park Medi World shares gain after ₹245 Cr deal to acquire KP Institute of Medical SciencesPark Medi World shares gain after ₹245 Cr deal to acquire KP Institute of Medical Sciences

Introduction

Leading healthcare provider expands presence in North India by acquiring a 360-bed hospital in Agra, aiming to enhance regional medical services, improve efficiency, and strengthen patient-focused healthcare delivery.

Also Read: Cyient Ltd gains after subsidiary to acquire a majority stake in Kinetic Technologies

Share price movement of Park Medi World

On December 19, 2025, Park Medi World Ltd opened at ₹158.50, up 2.15% from its previous close of ₹155.40. The stock reached a high of ₹162.50 (4.50%) and a low of ₹152.50. By 11:15 AM, it traded at ₹153.75, a 1.06% decrease, with a market cap of ₹6,640.94 crore.

Park Medi World Acquires Agra Hospital

Park Medi World Limited announced the acquisition of KP Institute of Medical Sciences (KPIMS) in Agra for ₹245 crore. The hospital has a total capacity of 360 beds.

The acquisition aligns with Park Medi World’s cluster-based growth strategy. The company aims to maximize operational efficiencies, achieve economies of scale, and strengthen its presence in key North Indian urban centres.

Park Medi World plans to integrate KPIMS immediately. The company will enhance clinical programs, improve efficiency, and provide advanced, patient-focused healthcare to meet regional demand in Agra and surrounding areas.

Also Read: Paytm receives RBI Authorisation for physical and cross-border payments, One 97 Communications stocks in focus

Shareholding pattern of Park Medi World

Particulars	Dec 2025
Promoter	82.90%
FII	2.00%
DII	6.70%
Public	9%

About Park Medi World

Park Medi World Ltd (NSE: PARKHOSPS) operates hospitals, nursing homes, clinics, and dispensaries across North India. The company provides healthcare services, maternity care, child welfare, and family planning, focusing on accessible and quality medical solutions.

Stay Ahead with the Latest Stock Market Updates – Click Here

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.

FAQs